Vital Access designs and manufactures surgical and interventional technologies to improve vascular access for patients and their caregivers. Vascular access challenges have driven the company to develop the VWING Vascular Needle Guide, which is currently approved for use in markets such as the United States, Canada, Europe and New Zealand.
Vital Access and its employees are committed to quality and improving patient care. Our focus is developing solutions for access surgeons, clinicians and patients.
Vital Access Corp. was founded by Duane Blatter, MD and was incorporated in Salt Lake City, Utah in July 2006. The goal of the company was to develop less-invasive technologies to help patients requiring vascular access.
Doug Smith joined the company in 2008 as President and CEO. Soon after, the talented Vital Access team, led by Doug Smith and Duane Blatter, MD, developed the VWING and began preparations to bring the product to market.
VWING was first used in a human on June 11, 2010, received CE Marking on January 22, 2012 and granted 510(k) clearance on September 13, 2013.
Vital Access occupies a facility with approximately 6,000 square feet of space. The facility also includes a research and development laboratory, a quality assurance laboratory, and office space to support both current and future production.
Vital Access and its employees are committed to quality and improving patient care.
Vital Access operates under an ISO 13485:2003 certified quality management system.
The company received its ISO 13485:2003 certification on June 6, 2011.
Vital Access received CE Marking for its VWING on January 22, 2012.
Vital Access was granted 510(k) clearance for its VWING on September 13, 2013.
Vital Access’s QA Lab houses state–of–the–art equipment, allowing our skilled Quality Control staff to ensure that our products meet their specifications.